Taiho Pharma Zipalertinib Shows Promise in Pivotal Phase 2b Trial
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology announced positive Phase 2b results from the REZILIENT1 trial of zipalertinib, an...
Jon Napitupulu
Adagene Announces Updated Data from Phase 1b/2 Study of Muza in Colorectal Cancer at ASCO
Adagene Inc. released updated Phase 1b/2 clinical trial data for ADG126, a novel anti-CTLA-4 antibody, combined with pembrolizumab in...
Candel Therapeutics’ Positive Phase 3 Results in Prostate Cancer
Candel Therapeutics announced positive Phase 3 trial results for aglatimagene besadenovec (CAN-2409) combined with valacyclovir in patients with intermediate-to-high-risk...
Tinlarebant Gets Breakthrough Therapy Tag for Stargardt Disease
Belite Bio has received Breakthrough Therapy Designation from the FDA for Tinlarebant, its treatment for Stargardt disease (STGD1), based...
Vykat™ XR Improves Hyperphagia and Behavioral Symptoms in PWS
Soleno Therapeutics announced positive data from its clinical development program for VYKAT XR (diazoxide choline) extended-release tablets, a treatment...
Advanced Skin Cancer Patient in Remission After WTX-124 Trial
A patient with advanced cutaneous squamous cell carcinoma (CSCC) experienced complete tumor remission after 12 weeks in a clinical...
ORUKA Therapeutics Doses First Participants in Phase 1 Trial of Anti-IL-17A/F Antibody
Oruka Therapeutics has started dosing healthy volunteers in a Phase 1 clinical trial for ORKA-002, a novel subcutaneous monoclonal...
Lymphodepletion Improves T Cell Expansion in Lymphoma Patients
Marker Therapeutics announced preliminary findings from its Phase 1 APOLLO study, showing that lymphodepletion, a pre-conditioning regimen, improves the...
Cingulate ADHD Study: CTX-1301 Efficacy Results Announced
Cingulate Inc. announced positive efficacy results from a Phase 3 clinical trial of CTx-1301, its dexmethylphenidate-based ADHD treatment, in...
SPRINT PNS Meets Primary Endpoint in MONARCH Study
SPR announced positive results from its MONARCH study, which investigated the use of its SPRINT PNS System for treating...